Corporate Social Responsibilities of Big Pharma: The case of Mylan Pharmaceuticals
08/31/2016
Questions about Business Ethics in Pricing the EpiPen Last Wednesday it was reported that the price of EpiPen, a life-saving injection device, had increased by 671 percent between 2007 and 2010. The public outcry led Mylan, the company that produces the EpiPen, to announce it would develop a generic brand... Read more →